Cite
Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC).
MLA
Bodor, J.Nicholas, et al. “Biomarkers for Immune Checkpoint Inhibition in Non-Small Cell Lung Cancer (NSCLC).” Cancer (0008543X), vol. 126, no. 2, Jan. 2020, pp. 260–70. EBSCOhost, https://doi.org/10.1002/cncr.32468.
APA
Bodor, J. N., Boumber, Y., & Borghaei, H. (2020). Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC). Cancer (0008543X), 126(2), 260–270. https://doi.org/10.1002/cncr.32468
Chicago
Bodor, J. Nicholas, Yanis Boumber, and Hossein Borghaei. 2020. “Biomarkers for Immune Checkpoint Inhibition in Non-Small Cell Lung Cancer (NSCLC).” Cancer (0008543X) 126 (2): 260–70. doi:10.1002/cncr.32468.